NCT04111757View on ClinicalTrials.gov

A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

August 6, 2021

Study Completion Date

August 6, 2021

Conditions
MyopiaMyopic Astigmatism
Interventions
DEVICE

Technolas® TENEO 317 Model 2

LASIK eye surgery

Trial Locations (10)

14228

Bausch Site 102, Amherst

27401

Bausch Site 104, Greensboro

29464

Bausch Site 103, Mt. Pleasant

55420

Bausch Site 107, Bloomington

55434

Bausch Site 110, Blaine

57108

Bausch Site 109, Sioux Falls

68105

Bausch Site 108, Omaha

78613

Bausch Site 105, Cedar Park

92663

Bausch Site 101, Newport Beach

03801

Bausch Site 106, Portsmouth

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT04111757 - A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism | Biotech Hunter | Biotech Hunter